Marc Gurwith

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “A replication-competent adenovirus-vectored influenza vaccine induces durable systemic and mucosal immunity”.

A replication-competent adenovirus-vectored influenza vaccine induces durable systemic and mucosal immunity

Journal of Clinical Investigation(2021)10.1172/jci140794

N/A

2.3DataRank · unranked

81 citations

Stephen A. Migueles, Jinghe Huang, Lyuba Bolkhovitinov, Sarah Stuccio, Trevor Griesman +23 more

Pre-Clinical Development of a Recombinant, Replication-Competent Adenovirus Serotype 4 Vector Vaccine Expressing HIV-1 Envelope 1086 Clade C

UNC Libraries(2020)10.17615/3ftd-ng87

N/A

0DataRank · unranked

0 citations

Peggy Farness, David C. Montefiori, Robert E. Parks, Jenny B. Avanzini, Lo Vang +13 more

A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Moderna COVID-19 Vaccine (mRNA-1273)

Vaccine(2022)10.1016/j.vaccine.2022.06.005

N/A

0DataRank · unranked

8 citations

Walter L. Straus, P. White, Alison Leav, Tashawnee Gaines, Grace Maggiacomo +5 more

A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Novavax COVID-19 Vaccine (NVX-CoV2373), a recombinant spike protein vaccine with Matrix-M adjuvant to prevent disease caused by SARS-CoV-2 viruses

Vaccine(2023)10.1016/j.vaccine.2023.07.040

N/A

0DataRank · unranked

3 citations

Kinjal S. Patel, Katherine R. Smith, Robert Walker, Chengbin Wang, Ann M. Greene +5 more

A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the emergent vesicular stomatitis virus (VSV) viral vector vaccine for Lassa fever

Vaccine(2025)10.1016/j.vaccine.2025.127137

N/A

0DataRank · unranked

0 citations

Melissa Wynn, L. J. Charles, Stefan Hamm, Demetrius Matassov, Cheryl Gerardi +4 more